#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=Ageing is a naturally occurring physiological process which is characterized by both physical and cognitive decline .
3-1	17-23	Ageing	_	_	_	_
3-2	24-26	is	_	_	_	_
3-3	27-28	a	abstract[3]	new[3]	_	_
3-4	29-38	naturally	abstract[3]	new[3]	_	_
3-5	39-48	occurring	abstract[3]	new[3]	_	_
3-6	49-62	physiological	abstract[3]	new[3]	_	_
3-7	63-70	process	abstract[3]	new[3]	_	_
3-8	71-76	which	_	_	_	_
3-9	77-79	is	_	_	_	_
3-10	80-93	characterized	_	_	_	_
3-11	94-96	by	_	_	_	_
3-12	97-101	both	abstract[4]	new[4]	coref	6-27[33_4]
3-13	102-110	physical	abstract[4]	new[4]	_	_
3-14	111-114	and	abstract[4]	new[4]	_	_
3-15	115-124	cognitive	abstract[4]	new[4]	_	_
3-16	125-132	decline	abstract[4]	new[4]	_	_
3-17	133-134	.	_	_	_	_

#Text=Changes are seen in brain neurochemistry as well as in neuroanatomical structures , which negatively affect synaptic plasticity and contribute to atrophy .
4-1	135-142	Changes	organization	new	coref	5-20
4-2	143-146	are	_	_	_	_
4-3	147-151	seen	_	_	_	_
4-4	152-154	in	_	_	_	_
4-5	155-160	brain	object|abstract[7]	new|new[7]	coref|coref	6-8|6-8
4-6	161-175	neurochemistry	abstract[7]	new[7]	_	_
4-7	176-178	as	_	_	_	_
4-8	179-183	well	_	_	_	_
4-9	184-186	as	_	_	_	_
4-10	187-189	in	_	_	_	_
4-11	190-205	neuroanatomical	object[8]	new[8]	_	_
4-12	206-216	structures	object[8]	new[8]	_	_
4-13	217-218	,	_	_	_	_
4-14	219-224	which	_	_	_	_
4-15	225-235	negatively	_	_	_	_
4-16	236-242	affect	_	_	_	_
4-17	243-251	synaptic	abstract[9]	new[9]	_	_
4-18	252-262	plasticity	abstract[9]	new[9]	_	_
4-19	263-266	and	_	_	_	_
4-20	267-277	contribute	_	_	_	_
4-21	278-280	to	_	_	_	_
4-22	281-288	atrophy	abstract	new	_	_
4-23	289-290	.	_	_	_	_

#Text=Ageing is also associated with increased vulnerability of the neurons to oxidative stress , emphasizing the potential importance of changes in the concentration of neurotrophic factors such as a decrease in the concentrations of brain-derived neurotrophic factor ( BDNF ) , which supports the growth and maintenance of neurons .
5-1	291-297	Ageing	_	_	_	_
5-2	298-300	is	_	_	_	_
5-3	301-305	also	_	_	_	_
5-4	306-316	associated	_	_	_	_
5-5	317-321	with	_	_	_	_
5-6	322-331	increased	abstract[11]	new[11]	_	_
5-7	332-345	vulnerability	abstract[11]	new[11]	_	_
5-8	346-348	of	abstract[11]	new[11]	_	_
5-9	349-352	the	abstract[11]|object[12]	new[11]|new[12]	coref	5-49[0_12]
5-10	353-360	neurons	abstract[11]|object[12]	new[11]|new[12]	_	_
5-11	361-363	to	abstract[11]|object[12]	new[11]|new[12]	_	_
5-12	364-373	oxidative	abstract[11]|object[12]|abstract[13]	new[11]|new[12]|new[13]	coref	6-19[31_13]
5-13	374-380	stress	abstract[11]|object[12]|abstract[13]	new[11]|new[12]|new[13]	_	_
5-14	381-382	,	_	_	_	_
5-15	383-394	emphasizing	_	_	_	_
5-16	395-398	the	abstract[14]	new[14]	_	_
5-17	399-408	potential	abstract[14]	new[14]	_	_
5-18	409-419	importance	abstract[14]	new[14]	_	_
5-19	420-422	of	abstract[14]	new[14]	_	_
5-20	423-430	changes	abstract[14]|abstract	new[14]|giv	_	_
5-21	431-433	in	abstract[14]	new[14]	_	_
5-22	434-437	the	abstract[14]|abstract[16]	new[14]|new[16]	_	_
5-23	438-451	concentration	abstract[14]|abstract[16]	new[14]|new[16]	_	_
5-24	452-454	of	abstract[14]|abstract[16]	new[14]|new[16]	_	_
5-25	455-467	neurotrophic	abstract[14]|abstract[16]|abstract[17]	new[14]|new[16]|new[17]	coref	6-4[26_17]
5-26	468-475	factors	abstract[14]|abstract[16]|abstract[17]	new[14]|new[16]|new[17]	_	_
5-27	476-480	such	abstract[14]|abstract[16]|abstract[17]	new[14]|new[16]|new[17]	_	_
5-28	481-483	as	abstract[14]|abstract[16]|abstract[17]	new[14]|new[16]|new[17]	_	_
5-29	484-485	a	abstract[14]|abstract[16]|abstract[17]|event[18]	new[14]|new[16]|new[17]|new[18]	_	_
5-30	486-494	decrease	abstract[14]|abstract[16]|abstract[17]|event[18]	new[14]|new[16]|new[17]|new[18]	_	_
5-31	495-497	in	abstract[14]|abstract[16]|abstract[17]|event[18]	new[14]|new[16]|new[17]|new[18]	_	_
5-32	498-501	the	abstract[14]|abstract[16]|abstract[17]|event[18]|abstract[19]	new[14]|new[16]|new[17]|new[18]|new[19]	_	_
5-33	502-516	concentrations	abstract[14]|abstract[16]|abstract[17]|event[18]|abstract[19]	new[14]|new[16]|new[17]|new[18]|new[19]	_	_
5-34	517-519	of	abstract[14]|abstract[16]|abstract[17]|event[18]|abstract[19]	new[14]|new[16]|new[17]|new[18]|new[19]	_	_
5-35	520-533	brain-derived	abstract[14]|abstract[16]|abstract[17]|event[18]|abstract[19]|abstract[20]	new[14]|new[16]|new[17]|new[18]|new[19]|new[20]	appos	5-39[0_20]
5-36	534-546	neurotrophic	abstract[14]|abstract[16]|abstract[17]|event[18]|abstract[19]|abstract[20]	new[14]|new[16]|new[17]|new[18]|new[19]|new[20]	_	_
5-37	547-553	factor	abstract[14]|abstract[16]|abstract[17]|event[18]|abstract[19]|abstract[20]	new[14]|new[16]|new[17]|new[18]|new[19]|new[20]	_	_
5-38	554-555	(	_	_	_	_
5-39	556-560	BDNF	abstract	giv	_	_
5-40	561-562	)	_	_	_	_
5-41	563-564	,	_	_	_	_
5-42	565-570	which	_	_	_	_
5-43	571-579	supports	_	_	_	_
5-44	580-583	the	abstract[22]	new[22]	_	_
5-45	584-590	growth	abstract[22]	new[22]	_	_
5-46	591-594	and	_	_	_	_
5-47	595-606	maintenance	abstract[23]	new[23]	_	_
5-48	607-609	of	abstract[23]	new[23]	_	_
5-49	610-617	neurons	abstract[23]|object	new[23]|giv	_	_
5-50	618-619	.	_	_	_	_

#Text=Decreased concentrations of such neurotrophic factors render brain cells more prone to damage caused by inflammatory processes and oxidative stress , which are key events in age-associated cognitive decline and neurodegenerative disease pathogenesis experienced by many older adults .
6-1	620-629	Decreased	abstract[25]	new[25]	coref	23-14[184_25]
6-2	630-644	concentrations	abstract[25]	new[25]	_	_
6-3	645-647	of	abstract[25]	new[25]	_	_
6-4	648-652	such	abstract[25]|abstract[26]	new[25]|giv[26]	coref	11-5[68_26]
6-5	653-665	neurotrophic	abstract[25]|abstract[26]	new[25]|giv[26]	_	_
6-6	666-673	factors	abstract[25]|abstract[26]	new[25]|giv[26]	_	_
6-7	674-680	render	_	_	_	_
6-8	681-686	brain	object|object[28]	giv|new[28]	coref|coref	12-13|12-13
6-9	687-692	cells	object[28]	new[28]	_	_
6-10	693-697	more	_	_	_	_
6-11	698-703	prone	_	_	_	_
6-12	704-706	to	_	_	_	_
6-13	707-713	damage	abstract	new	coref	13-33[96_0]
6-14	714-720	caused	_	_	_	_
6-15	721-723	by	_	_	_	_
6-16	724-736	inflammatory	abstract[30]	new[30]	coref	14-13[101_30]
6-17	737-746	processes	abstract[30]	new[30]	_	_
6-18	747-750	and	_	_	_	_
6-19	751-760	oxidative	abstract[31]	giv[31]	coref	9-15[56_31]
6-20	761-767	stress	abstract[31]	giv[31]	_	_
6-21	768-769	,	_	_	_	_
6-22	770-775	which	_	_	_	_
6-23	776-779	are	_	_	_	_
6-24	780-783	key	event[32]	new[32]	_	_
6-25	784-790	events	event[32]	new[32]	_	_
6-26	791-793	in	event[32]	new[32]	_	_
6-27	794-808	age-associated	event[32]|abstract[33]	new[32]|giv[33]	coref	7-14[40_33]
6-28	809-818	cognitive	event[32]|abstract[33]	new[32]|giv[33]	_	_
6-29	819-826	decline	event[32]|abstract[33]	new[32]|giv[33]	_	_
6-30	827-830	and	event[32]	new[32]	_	_
6-31	831-848	neurodegenerative	event[32]|abstract[35]	new[32]|new[35]	ana	7-4[0_35]
6-32	849-856	disease	event[32]|abstract|abstract[35]	new[32]|new|new[35]	_	_
6-33	857-869	pathogenesis	event[32]|abstract[35]	new[32]|new[35]	_	_
6-34	870-881	experienced	_	_	_	_
6-35	882-884	by	_	_	_	_
6-36	885-889	many	person[36]	new[36]	coref	23-38[192_36]
6-37	890-895	older	person[36]	new[36]	_	_
6-38	896-902	adults	person[36]	new[36]	_	_
6-39	903-904	.	_	_	_	_

#Text=In fact , it is estimated that dementia , a far-end result of cognitive decline , affects approximately 50 million people worldwide .
7-1	905-907	In	_	_	_	_
7-2	908-912	fact	_	_	_	_
7-3	913-914	,	_	_	_	_
7-4	915-917	it	abstract	giv	_	_
7-5	918-920	is	_	_	_	_
7-6	921-930	estimated	_	_	_	_
7-7	931-935	that	abstract[38]	new[38]	appos	7-10[39_38]
7-8	936-944	dementia	abstract[38]	new[38]	_	_
7-9	945-946	,	_	_	_	_
7-10	947-948	a	abstract[39]	giv[39]	coref	9-1[0_39]
7-11	949-956	far-end	abstract[39]	giv[39]	_	_
7-12	957-963	result	abstract[39]	giv[39]	_	_
7-13	964-966	of	abstract[39]	giv[39]	_	_
7-14	967-976	cognitive	abstract[39]|abstract[40]	giv[39]|giv[40]	_	_
7-15	977-984	decline	abstract[39]|abstract[40]	giv[39]|giv[40]	_	_
7-16	985-986	,	_	_	_	_
7-17	987-994	affects	_	_	_	_
7-18	995-1008	approximately	person[41]	new[41]	_	_
7-19	1009-1011	50	person[41]	new[41]	_	_
7-20	1012-1019	million	person[41]	new[41]	_	_
7-21	1020-1026	people	person[41]	new[41]	_	_
7-22	1027-1036	worldwide	_	_	_	_
7-23	1037-1038	.	_	_	_	_

#Text=This number is expected to increase to 75 million by 2030 and 132 million by 2050 , posing a considerable burden on the health care system .
8-1	1039-1043	This	quantity[42]	new[42]	_	_
8-2	1044-1050	number	quantity[42]	new[42]	_	_
8-3	1051-1053	is	_	_	_	_
8-4	1054-1062	expected	_	_	_	_
8-5	1063-1065	to	_	_	_	_
8-6	1066-1074	increase	_	_	_	_
8-7	1075-1077	to	_	_	_	_
8-8	1078-1080	75	quantity[43]	new[43]	_	_
8-9	1081-1088	million	quantity[43]	new[43]	_	_
8-10	1089-1091	by	_	_	_	_
8-11	1092-1096	2030	time	new	coref	11-22
8-12	1097-1100	and	_	_	_	_
8-13	1101-1104	132	quantity[45]	new[45]	_	_
8-14	1105-1112	million	quantity[45]	new[45]	_	_
8-15	1113-1115	by	_	_	_	_
8-16	1116-1120	2050	time	new	_	_
8-17	1121-1122	,	_	_	_	_
8-18	1123-1129	posing	_	_	_	_
8-19	1130-1131	a	abstract[47]	new[47]	_	_
8-20	1132-1144	considerable	abstract[47]	new[47]	_	_
8-21	1145-1151	burden	abstract[47]	new[47]	_	_
8-22	1152-1154	on	abstract[47]	new[47]	_	_
8-23	1155-1158	the	abstract[47]|abstract[50]	new[47]|new[50]	_	_
8-24	1159-1165	health	abstract[47]|abstract|abstract[50]	new[47]|new|new[50]	_	_
8-25	1166-1170	care	abstract[47]|abstract|abstract[50]	new[47]|new|new[50]	_	_
8-26	1171-1177	system	abstract[47]|abstract[50]	new[47]|new[50]	_	_
8-27	1178-1179	.	_	_	_	_

#Text=Dementia is intrinsically linked with depression , as both are characterized by neuroinflammation and oxidative stress .
9-1	1180-1188	Dementia	abstract	giv	coref	10-35
9-2	1189-1191	is	_	_	_	_
9-3	1192-1205	intrinsically	_	_	_	_
9-4	1206-1212	linked	_	_	_	_
9-5	1213-1217	with	_	_	_	_
9-6	1218-1228	depression	abstract	new	ana	9-9
9-7	1229-1230	,	_	_	_	_
9-8	1231-1233	as	_	_	_	_
9-9	1234-1238	both	abstract	giv	coref	10-1
9-10	1239-1242	are	_	_	_	_
9-11	1243-1256	characterized	_	_	_	_
9-12	1257-1259	by	_	_	_	_
9-13	1260-1277	neuroinflammation	abstract	new	_	_
9-14	1278-1281	and	_	_	_	_
9-15	1282-1291	oxidative	abstract|abstract[56]	new|giv[56]	coref|coref|coref|coref	19-20|19-20[150_56]|19-20|19-20[150_56]
9-16	1292-1298	stress	abstract[56]	giv[56]	_	_
9-17	1299-1300	.	_	_	_	_

#Text=Depression is a complex disease involving a chronic low-grade inflammatory response , activation of cell-mediated immunity , and progressive neuropathology , which can lead to neurodegeneration and later on contribute toward the development of dementia .
10-1	1301-1311	Depression	abstract	giv	coref	10-3[58_0]
10-2	1312-1314	is	_	_	_	_
10-3	1315-1316	a	abstract[58]	giv[58]	coref	11-11[0_58]
10-4	1317-1324	complex	abstract[58]	giv[58]	_	_
10-5	1325-1332	disease	abstract[58]	giv[58]	_	_
10-6	1333-1342	involving	_	_	_	_
10-7	1343-1344	a	abstract[59]	new[59]	coref	13-13[90_59]
10-8	1345-1352	chronic	abstract[59]	new[59]	_	_
10-9	1353-1362	low-grade	abstract[59]	new[59]	_	_
10-10	1363-1375	inflammatory	abstract[59]	new[59]	_	_
10-11	1376-1384	response	abstract[59]	new[59]	_	_
10-12	1385-1386	,	_	_	_	_
10-13	1387-1397	activation	event[60]	new[60]	_	_
10-14	1398-1400	of	event[60]	new[60]	_	_
10-15	1401-1414	cell-mediated	event[60]|abstract[61]	new[60]|new[61]	_	_
10-16	1415-1423	immunity	event[60]|abstract[61]	new[60]|new[61]	_	_
10-17	1424-1425	,	_	_	_	_
10-18	1426-1429	and	_	_	_	_
10-19	1430-1441	progressive	abstract[62]	new[62]	_	_
10-20	1442-1456	neuropathology	abstract[62]	new[62]	_	_
10-21	1457-1458	,	_	_	_	_
10-22	1459-1464	which	_	_	_	_
10-23	1465-1468	can	_	_	_	_
10-24	1469-1473	lead	_	_	_	_
10-25	1474-1476	to	_	_	_	_
10-26	1477-1494	neurodegeneration	abstract	new	coref	12-29
10-27	1495-1498	and	_	_	_	_
10-28	1499-1504	later	_	_	_	_
10-29	1505-1507	on	_	_	_	_
10-30	1508-1518	contribute	_	_	_	_
10-31	1519-1525	toward	_	_	_	_
10-32	1526-1529	the	event[64]	new[64]	_	_
10-33	1530-1541	development	event[64]	new[64]	_	_
10-34	1542-1544	of	event[64]	new[64]	_	_
10-35	1545-1553	dementia	event[64]|abstract	new[64]|giv	coref	11-9
10-36	1554-1555	.	_	_	_	_

#Text=Besides being one of many risk factors for dementia , depression is estimated to be the leading cause of disability by 2030 .
11-1	1556-1563	Besides	_	_	_	_
11-2	1564-1569	being	_	_	_	_
11-3	1570-1573	one	abstract[66]	new[66]	_	_
11-4	1574-1576	of	abstract[66]	new[66]	_	_
11-5	1577-1581	many	abstract[66]|abstract[68]	new[66]|giv[68]	coref	23-25[187_68]
11-6	1582-1586	risk	abstract[66]|abstract|abstract[68]	new[66]|new|giv[68]	coref	18-10[133_0]
11-7	1587-1594	factors	abstract[66]|abstract[68]	new[66]|giv[68]	_	_
11-8	1595-1598	for	abstract[66]|abstract[68]	new[66]|giv[68]	_	_
11-9	1599-1607	dementia	abstract[66]|abstract[68]|abstract	new[66]|giv[68]|giv	coref	15-35
11-10	1608-1609	,	_	_	_	_
11-11	1610-1620	depression	abstract	giv	coref	18-33[141_0]
11-12	1621-1623	is	_	_	_	_
11-13	1624-1633	estimated	_	_	_	_
11-14	1634-1636	to	_	_	_	_
11-15	1637-1639	be	_	_	_	_
11-16	1640-1643	the	abstract[71]	new[71]	_	_
11-17	1644-1651	leading	abstract[71]	new[71]	_	_
11-18	1652-1657	cause	abstract[71]	new[71]	_	_
11-19	1658-1660	of	abstract[71]	new[71]	_	_
11-20	1661-1671	disability	abstract[71]|abstract	new[71]|new	_	_
11-21	1672-1674	by	abstract[71]	new[71]	_	_
11-22	1675-1679	2030	abstract[71]|time	new[71]|giv	_	_
11-23	1680-1681	.	_	_	_	_

#Text=Metal ions such as copper and zinc play an essential role in brain function and neuronal homeostasis , and long-term imbalance of these metals has been linked to neurodegeneration and neurological disorder .
12-1	1682-1687	Metal	person|substance[75]	new|new[75]	_	_
12-2	1688-1692	ions	substance[75]	new[75]	_	_
12-3	1693-1697	such	substance[75]	new[75]	_	_
12-4	1698-1700	as	substance[75]	new[75]	_	_
12-5	1701-1707	copper	substance[75]|substance|substance[77]	new[75]|new|new[77]	coref|coref|coref|coref	14-1|20-11[156_77]|14-1|20-11[156_77]
12-6	1708-1711	and	substance[75]|substance[77]	new[75]|new[77]	_	_
12-7	1712-1716	zinc	substance[75]|substance[77]|substance	new[75]|new[77]|new	coref	16-5[116_0]
12-8	1717-1721	play	_	_	_	_
12-9	1722-1724	an	abstract[79]	new[79]	coref	19-9[145_79]
12-10	1725-1734	essential	abstract[79]	new[79]	_	_
12-11	1735-1739	role	abstract[79]	new[79]	_	_
12-12	1740-1742	in	abstract[79]	new[79]	_	_
12-13	1743-1748	brain	abstract[79]|object|abstract[81]	new[79]|giv|new[81]	coref|coref|coref|coref	13-18[91_0]|23-28[188_81]|13-18[91_0]|23-28[188_81]
12-14	1749-1757	function	abstract[79]|abstract[81]	new[79]|new[81]	_	_
12-15	1758-1761	and	abstract[79]	new[79]	_	_
12-16	1762-1770	neuronal	abstract[79]|abstract[82]	new[79]|new[82]	_	_
12-17	1771-1782	homeostasis	abstract[79]|abstract[82]	new[79]|new[82]	_	_
12-18	1783-1784	,	_	_	_	_
12-19	1785-1788	and	_	_	_	_
12-20	1789-1798	long-term	abstract[83]	new[83]	_	_
12-21	1799-1808	imbalance	abstract[83]	new[83]	_	_
12-22	1809-1811	of	abstract[83]	new[83]	_	_
12-23	1812-1817	these	abstract[83]|substance[84]	new[83]|new[84]	coref	20-21[160_84]
12-24	1818-1824	metals	abstract[83]|substance[84]	new[83]|new[84]	_	_
12-25	1825-1828	has	_	_	_	_
12-26	1829-1833	been	_	_	_	_
12-27	1834-1840	linked	_	_	_	_
12-28	1841-1843	to	_	_	_	_
12-29	1844-1861	neurodegeneration	abstract	giv	_	_
12-30	1862-1865	and	_	_	_	_
12-31	1866-1878	neurological	abstract[86]	new[86]	ana	13-1[0_86]
12-32	1879-1887	disorder	abstract[86]	new[86]	_	_
12-33	1888-1889	.	_	_	_	_

#Text=It is thought that this may be due to the provocation of an unchecked immune response within the brain via the increased production of reactive oxygen species , which can lead to brain damage via the upregulation of inflammatory mediators .
13-1	1890-1892	It	abstract	giv	ana	13-5
13-2	1893-1895	is	_	_	_	_
13-3	1896-1903	thought	_	_	_	_
13-4	1904-1908	that	_	_	_	_
13-5	1909-1913	this	abstract	giv	_	_
13-6	1914-1917	may	_	_	_	_
13-7	1918-1920	be	_	_	_	_
13-8	1921-1924	due	_	_	_	_
13-9	1925-1927	to	_	_	_	_
13-10	1928-1931	the	abstract[89]	new[89]	_	_
13-11	1932-1943	provocation	abstract[89]	new[89]	_	_
13-12	1944-1946	of	abstract[89]	new[89]	_	_
13-13	1947-1949	an	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
13-14	1950-1959	unchecked	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
13-15	1960-1966	immune	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
13-16	1967-1975	response	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
13-17	1976-1982	within	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
13-18	1983-1986	the	abstract[89]|abstract[90]|object[91]	new[89]|giv[90]|giv[91]	coref	13-33[0_91]
13-19	1987-1992	brain	abstract[89]|abstract[90]|object[91]	new[89]|giv[90]|giv[91]	_	_
13-20	1993-1996	via	abstract[89]|abstract[90]|object[91]	new[89]|giv[90]|giv[91]	_	_
13-21	1997-2000	the	abstract[89]|abstract[90]|object[91]|event[92]	new[89]|giv[90]|giv[91]|new[92]	_	_
13-22	2001-2010	increased	abstract[89]|abstract[90]|object[91]|event[92]	new[89]|giv[90]|giv[91]|new[92]	_	_
13-23	2011-2021	production	abstract[89]|abstract[90]|object[91]|event[92]	new[89]|giv[90]|giv[91]|new[92]	_	_
13-24	2022-2024	of	abstract[89]|abstract[90]|object[91]|event[92]	new[89]|giv[90]|giv[91]|new[92]	_	_
13-25	2025-2033	reactive	abstract[89]|abstract[90]|object[91]|event[92]|abstract[94]	new[89]|giv[90]|giv[91]|new[92]|new[94]	_	_
13-26	2034-2040	oxygen	abstract[89]|abstract[90]|object[91]|event[92]|substance|abstract[94]	new[89]|giv[90]|giv[91]|new[92]|new|new[94]	_	_
13-27	2041-2048	species	abstract[89]|abstract[90]|object[91]|event[92]|abstract[94]	new[89]|giv[90]|giv[91]|new[92]|new[94]	_	_
13-28	2049-2050	,	_	_	_	_
13-29	2051-2056	which	_	_	_	_
13-30	2057-2060	can	_	_	_	_
13-31	2061-2065	lead	_	_	_	_
13-32	2066-2068	to	_	_	_	_
13-33	2069-2074	brain	object|abstract[96]	giv|giv[96]	coref|coref	15-16[109_0]|15-16[109_0]
13-34	2075-2081	damage	abstract[96]	giv[96]	_	_
13-35	2082-2085	via	abstract[96]	giv[96]	_	_
13-36	2086-2089	the	abstract[96]|event[97]	giv[96]|new[97]	_	_
13-37	2090-2102	upregulation	abstract[96]|event[97]	giv[96]|new[97]	_	_
13-38	2103-2105	of	abstract[96]|event[97]	giv[96]|new[97]	_	_
13-39	2106-2118	inflammatory	abstract[96]|event[97]|person[98]	giv[96]|new[97]|new[98]	_	_
13-40	2119-2128	mediators	abstract[96]|event[97]|person[98]	giv[96]|new[97]|new[98]	_	_
13-41	2129-2130	.	_	_	_	_

#Text=Copper is an essential transition metal that acts as a catalyst for several biological processes such as the synthesis of neurotransmitters .
14-1	2131-2137	Copper	substance	giv	coref	14-3[100_0]
14-2	2138-2140	is	_	_	_	_
14-3	2141-2143	an	substance[100]	giv[100]	coref	16-1[0_100]
14-4	2144-2153	essential	substance[100]	giv[100]	_	_
14-5	2154-2164	transition	substance[100]	giv[100]	_	_
14-6	2165-2170	metal	substance[100]	giv[100]	_	_
14-7	2171-2175	that	_	_	_	_
14-8	2176-2180	acts	_	_	_	_
14-9	2181-2183	as	_	_	_	_
14-10	2184-2185	a	_	_	_	_
14-11	2186-2194	catalyst	_	_	_	_
14-12	2195-2198	for	_	_	_	_
14-13	2199-2206	several	abstract[101]	giv[101]	coref	17-7[124_101]
14-14	2207-2217	biological	abstract[101]	giv[101]	_	_
14-15	2218-2227	processes	abstract[101]	giv[101]	_	_
14-16	2228-2232	such	abstract[101]	giv[101]	_	_
14-17	2233-2235	as	abstract[101]	giv[101]	_	_
14-18	2236-2239	the	abstract[101]|event[102]	giv[101]|new[102]	_	_
14-19	2240-2249	synthesis	abstract[101]|event[102]	giv[101]|new[102]	_	_
14-20	2250-2252	of	abstract[101]|event[102]	giv[101]|new[102]	_	_
14-21	2253-2270	neurotransmitters	abstract[101]|event[102]|event	giv[101]|new[102]|new	_	_
14-22	2271-2272	.	_	_	_	_

#Text=However , disturbance of its transport , causing accumulation in the blood and depletion in the brain , has been linked with neurodegenerative diseases such as Alzheimer ’s , the most common form of dementia .
15-1	2273-2280	However	_	_	_	_
15-2	2281-2282	,	_	_	_	_
15-3	2283-2294	disturbance	abstract[104]	new[104]	_	_
15-4	2295-2297	of	abstract[104]	new[104]	_	_
15-5	2298-2301	its	abstract[104]|abstract[105]	new[104]|new[105]	_	_
15-6	2302-2311	transport	abstract[104]|abstract[105]	new[104]|new[105]	_	_
15-7	2312-2313	,	_	_	_	_
15-8	2314-2321	causing	_	_	_	_
15-9	2322-2334	accumulation	abstract[106]	new[106]	_	_
15-10	2335-2337	in	abstract[106]	new[106]	_	_
15-11	2338-2341	the	abstract[106]|substance[107]	new[106]|new[107]	_	_
15-12	2342-2347	blood	abstract[106]|substance[107]	new[106]|new[107]	_	_
15-13	2348-2351	and	abstract[106]	new[106]	_	_
15-14	2352-2361	depletion	abstract[106]|event[108]	new[106]|new[108]	_	_
15-15	2362-2364	in	abstract[106]|event[108]	new[106]|new[108]	_	_
15-16	2365-2368	the	abstract[106]|event[108]|object[109]	new[106]|new[108]|giv[109]	_	_
15-17	2369-2374	brain	abstract[106]|event[108]|object[109]	new[106]|new[108]|giv[109]	_	_
15-18	2375-2376	,	_	_	_	_
15-19	2377-2380	has	_	_	_	_
15-20	2381-2385	been	_	_	_	_
15-21	2386-2392	linked	_	_	_	_
15-22	2393-2397	with	_	_	_	_
15-23	2398-2415	neurodegenerative	abstract[110]	new[110]	_	_
15-24	2416-2424	diseases	abstract[110]	new[110]	_	_
15-25	2425-2429	such	abstract[110]	new[110]	_	_
15-26	2430-2432	as	abstract[110]	new[110]	_	_
15-27	2433-2442	Alzheimer	abstract[110]|abstract[111]	new[110]|new[111]	coref	19-13[146_111]
15-28	2443-2445	’s	abstract[110]|abstract[111]	new[110]|new[111]	_	_
15-29	2446-2447	,	_	_	_	_
15-30	2448-2451	the	abstract[112]	new[112]	_	_
15-31	2452-2456	most	abstract[112]	new[112]	_	_
15-32	2457-2463	common	abstract[112]	new[112]	_	_
15-33	2464-2468	form	abstract[112]	new[112]	_	_
15-34	2469-2471	of	abstract[112]	new[112]	_	_
15-35	2472-2480	dementia	abstract[112]|abstract	new[112]|giv	coref	18-13
15-36	2481-2482	.	_	_	_	_

#Text=Copper works synergistically with zinc in several metalloenzymes , such as the antioxidant enzyme superoxide dismutase .
16-1	2483-2489	Copper	substance|object[115]	giv|new[115]	coref|coref	17-19|17-19
16-2	2490-2495	works	object[115]	new[115]	_	_
16-3	2496-2511	synergistically	object[115]	new[115]	_	_
16-4	2512-2516	with	object[115]	new[115]	_	_
16-5	2517-2521	zinc	object[115]|substance[116]	new[115]|giv[116]	coref	17-1[0_116]
16-6	2522-2524	in	object[115]|substance[116]	new[115]|giv[116]	_	_
16-7	2525-2532	several	object[115]|substance[116]|substance[117]	new[115]|giv[116]|new[117]	_	_
16-8	2533-2547	metalloenzymes	object[115]|substance[116]|substance[117]	new[115]|giv[116]|new[117]	_	_
16-9	2548-2549	,	object[115]|substance[116]|substance[117]	new[115]|giv[116]|new[117]	_	_
16-10	2550-2554	such	object[115]|substance[116]|substance[117]	new[115]|giv[116]|new[117]	_	_
16-11	2555-2557	as	object[115]|substance[116]|substance[117]	new[115]|giv[116]|new[117]	_	_
16-12	2558-2561	the	object[115]|substance[116]|substance[117]|person[118]	new[115]|giv[116]|new[117]|new[118]	_	_
16-13	2562-2573	antioxidant	object[115]|substance[116]|substance[117]|person[118]	new[115]|giv[116]|new[117]|new[118]	_	_
16-14	2574-2580	enzyme	substance|substance[121]	new|new[121]	_	_
16-15	2581-2591	superoxide	substance|substance[121]	new|new[121]	_	_
16-16	2592-2601	dismutase	substance[121]	new[121]	_	_
16-17	2602-2603	.	_	_	_	_

#Text=Zinc is an essential component of numerous biochemical and molecular processes related to cell survival and , unlike copper , has very low toxicity in humans .
17-1	2604-2608	Zinc	abstract	giv	coref	17-3[123_0]
17-2	2609-2611	is	_	_	_	_
17-3	2612-2614	an	abstract[123]	giv[123]	coref	18-6[0_123]
17-4	2615-2624	essential	abstract[123]	giv[123]	_	_
17-5	2625-2634	component	abstract[123]	giv[123]	_	_
17-6	2635-2637	of	abstract[123]	giv[123]	_	_
17-7	2638-2646	numerous	abstract[123]|abstract[124]	giv[123]|giv[124]	_	_
17-8	2647-2658	biochemical	abstract[123]|abstract[124]	giv[123]|giv[124]	_	_
17-9	2659-2662	and	abstract[123]|abstract[124]	giv[123]|giv[124]	_	_
17-10	2663-2672	molecular	abstract[123]|abstract[124]	giv[123]|giv[124]	_	_
17-11	2673-2682	processes	abstract[123]|abstract[124]	giv[123]|giv[124]	_	_
17-12	2683-2690	related	_	_	_	_
17-13	2691-2693	to	_	_	_	_
17-14	2694-2698	cell	place|abstract[126]	new|new[126]	_	_
17-15	2699-2707	survival	abstract[126]	new[126]	_	_
17-16	2708-2711	and	_	_	_	_
17-17	2712-2713	,	_	_	_	_
17-18	2714-2720	unlike	_	_	_	_
17-19	2721-2727	copper	substance	giv	coref	19-3
17-20	2728-2729	,	_	_	_	_
17-21	2730-2733	has	_	_	_	_
17-22	2734-2738	very	abstract[128]	new[128]	_	_
17-23	2739-2742	low	abstract[128]	new[128]	_	_
17-24	2743-2751	toxicity	abstract[128]	new[128]	_	_
17-25	2752-2754	in	abstract[128]	new[128]	_	_
17-26	2755-2761	humans	abstract[128]|person	new[128]|new	_	_
17-27	2762-2763	.	_	_	_	_

#Text=However , research suggests that zinc deficiency may increase the risk of dementia , and thus supplementation with zinc may improve cognition and regulation of emotional behavior ( such as anger and depression ) in cognitively intact individuals .
18-1	2764-2771	However	_	_	_	_
18-2	2772-2773	,	_	_	_	_
18-3	2774-2782	research	abstract	new	_	_
18-4	2783-2791	suggests	_	_	_	_
18-5	2792-2796	that	_	_	_	_
18-6	2797-2801	zinc	substance|abstract[132]	giv|new[132]	coref|coref	18-19|18-19
18-7	2802-2812	deficiency	abstract[132]	new[132]	_	_
18-8	2813-2816	may	_	_	_	_
18-9	2817-2825	increase	_	_	_	_
18-10	2826-2829	the	abstract[133]	giv[133]	_	_
18-11	2830-2834	risk	abstract[133]	giv[133]	_	_
18-12	2835-2837	of	abstract[133]	giv[133]	_	_
18-13	2838-2846	dementia	abstract[133]|abstract	giv[133]|giv	coref	22-21
18-14	2847-2848	,	_	_	_	_
18-15	2849-2852	and	_	_	_	_
18-16	2853-2857	thus	substance[135]	new[135]	_	_
18-17	2858-2873	supplementation	substance[135]	new[135]	_	_
18-18	2874-2878	with	substance[135]	new[135]	_	_
18-19	2879-2883	zinc	substance[135]|substance	new[135]|giv	coref	19-24
18-20	2884-2887	may	_	_	_	_
18-21	2888-2895	improve	_	_	_	_
18-22	2896-2905	cognition	abstract	new	_	_
18-23	2906-2909	and	_	_	_	_
18-24	2910-2920	regulation	abstract[138]	new[138]	_	_
18-25	2921-2923	of	abstract[138]	new[138]	_	_
18-26	2924-2933	emotional	abstract[138]|abstract[139]	new[138]|new[139]	_	_
18-27	2934-2942	behavior	abstract[138]|abstract[139]	new[138]|new[139]	_	_
18-28	2943-2944	(	abstract[138]|abstract[139]	new[138]|new[139]	_	_
18-29	2945-2949	such	abstract[138]|abstract[139]	new[138]|new[139]	_	_
18-30	2950-2952	as	abstract[138]|abstract[139]	new[138]|new[139]	_	_
18-31	2953-2958	anger	abstract[138]|abstract[139]|abstract	new[138]|new[139]|new	_	_
18-32	2959-2962	and	abstract[138]|abstract[139]	new[138]|new[139]	_	_
18-33	2963-2973	depression	abstract[138]|abstract[139]|abstract[141]	new[138]|new[139]|giv[141]	coref	19-13[147_141]
18-34	2974-2975	)	abstract[138]|abstract[139]|abstract[141]	new[138]|new[139]|giv[141]	_	_
18-35	2976-2978	in	abstract[138]|abstract[139]|abstract[141]	new[138]|new[139]|giv[141]	_	_
18-36	2979-2990	cognitively	abstract[138]|abstract[139]|abstract[141]|person[142]	new[138]|new[139]|giv[141]|new[142]	coref	22-19[176_142]
18-37	2991-2997	intact	abstract[138]|abstract[139]|abstract[141]|person[142]	new[138]|new[139]|giv[141]|new[142]	_	_
18-38	2998-3009	individuals	abstract[138]|abstract[139]|abstract[141]|person[142]	new[138]|new[139]|giv[141]|new[142]	_	_
18-39	3010-3011	.	_	_	_	_

#Text=Zinc and copper are also likely to have a synergistic role in Alzheimer ’s disease , with copper promoting oxidative stress and displacing zinc from body tissues .
19-1	3012-3016	Zinc	person	new	_	_
19-2	3017-3020	and	_	_	_	_
19-3	3021-3027	copper	substance	giv	coref	19-18
19-4	3028-3031	are	_	_	_	_
19-5	3032-3036	also	_	_	_	_
19-6	3037-3043	likely	_	_	_	_
19-7	3044-3046	to	_	_	_	_
19-8	3047-3051	have	_	_	_	_
19-9	3052-3053	a	abstract[145]	giv[145]	_	_
19-10	3054-3065	synergistic	abstract[145]	giv[145]	_	_
19-11	3066-3070	role	abstract[145]	giv[145]	_	_
19-12	3071-3073	in	abstract[145]	giv[145]	_	_
19-13	3074-3083	Alzheimer	abstract[145]|abstract[146]|abstract[147]	giv[145]|giv[146]|giv[147]	_	_
19-14	3084-3086	’s	abstract[145]|abstract[146]|abstract[147]	giv[145]|giv[146]|giv[147]	_	_
19-15	3087-3094	disease	abstract[145]|abstract[147]	giv[145]|giv[147]	_	_
19-16	3095-3096	,	_	_	_	_
19-17	3097-3101	with	_	_	_	_
19-18	3102-3108	copper	substance	giv	coref	20-11
19-19	3109-3118	promoting	_	_	_	_
19-20	3119-3128	oxidative	abstract|abstract[150]	giv|giv[150]	coref|coref|coref|coref	21-22|21-22[170_150]|21-22|21-22[170_150]
19-21	3129-3135	stress	abstract[150]	giv[150]	_	_
19-22	3136-3139	and	_	_	_	_
19-23	3140-3150	displacing	_	_	_	_
19-24	3151-3155	zinc	substance	giv	coref	20-13[157_0]
19-25	3156-3160	from	_	_	_	_
19-26	3161-3165	body	object|object[153]	new|new[153]	_	_
19-27	3166-3173	tissues	object[153]	new[153]	_	_
19-28	3174-3175	.	_	_	_	_

#Text=Therefore , not only is the individual nutritional status of copper and zinc of concern , but the balance between these two metals appears to be important .
20-1	3176-3185	Therefore	_	_	_	_
20-2	3186-3187	,	_	_	_	_
20-3	3188-3191	not	_	_	_	_
20-4	3192-3196	only	_	_	_	_
20-5	3197-3199	is	_	_	_	_
20-6	3200-3203	the	abstract[154]	new[154]	coref	22-5[173_154]
20-7	3204-3214	individual	abstract[154]	new[154]	_	_
20-8	3215-3226	nutritional	abstract[154]	new[154]	_	_
20-9	3227-3233	status	abstract[154]	new[154]	_	_
20-10	3234-3236	of	abstract[154]	new[154]	_	_
20-11	3237-3243	copper	abstract[154]|substance|substance[156]	new[154]|giv|giv[156]	coref|coref	21-7[162_0]|21-7[162_0]
20-12	3244-3247	and	abstract[154]|substance[156]	new[154]|giv[156]	_	_
20-13	3248-3252	zinc	abstract[154]|substance[156]|substance[157]	new[154]|giv[156]|giv[157]	coref	21-10[0_157]
20-14	3253-3255	of	abstract[154]|substance[156]|substance[157]	new[154]|giv[156]|giv[157]	_	_
20-15	3256-3263	concern	abstract[154]|substance[156]|substance[157]|abstract	new[154]|giv[156]|giv[157]|new	_	_
20-16	3264-3265	,	_	_	_	_
20-17	3266-3269	but	_	_	_	_
20-18	3270-3273	the	abstract[159]	new[159]	_	_
20-19	3274-3281	balance	abstract[159]	new[159]	_	_
20-20	3282-3289	between	abstract[159]	new[159]	_	_
20-21	3290-3295	these	abstract[159]|substance[160]	new[159]|giv[160]	_	_
20-22	3296-3299	two	abstract[159]|substance[160]	new[159]|giv[160]	_	_
20-23	3300-3306	metals	abstract[159]|substance[160]	new[159]|giv[160]	_	_
20-24	3307-3314	appears	_	_	_	_
20-25	3315-3317	to	_	_	_	_
20-26	3318-3320	be	_	_	_	_
20-27	3321-3330	important	_	_	_	_
20-28	3331-3332	.	_	_	_	_

#Text=Indeed , studies suggest that calculating the copper to zinc ratio ( Cu/Zn ratio ) provides valuable information in regard to oxidative stress and inflammatory responses .
21-1	3333-3339	Indeed	_	_	_	_
21-2	3340-3341	,	_	_	_	_
21-3	3342-3349	studies	abstract	new	_	_
21-4	3350-3357	suggest	_	_	_	_
21-5	3358-3362	that	_	_	_	_
21-6	3363-3374	calculating	_	_	_	_
21-7	3375-3378	the	substance[162]	giv[162]	coref	23-11[181_162]
21-8	3379-3385	copper	substance[162]	giv[162]	_	_
21-9	3386-3388	to	_	_	_	_
21-10	3389-3393	zinc	substance|abstract[164]	giv|new[164]	appos|coref|appos|coref	21-13[166_164]|22-6|21-13[166_164]|22-6
21-11	3394-3399	ratio	abstract[164]	new[164]	_	_
21-12	3400-3401	(	_	_	_	_
21-13	3402-3407	Cu/Zn	abstract|abstract[166]	new|giv[166]	coref|coref|coref|coref	22-11|22-9[175_166]|22-11|22-9[175_166]
21-14	3408-3413	ratio	abstract[166]	giv[166]	_	_
21-15	3414-3415	)	_	_	_	_
21-16	3416-3424	provides	_	_	_	_
21-17	3425-3433	valuable	abstract[167]	new[167]	_	_
21-18	3434-3445	information	abstract[167]	new[167]	_	_
21-19	3446-3448	in	abstract[167]	new[167]	_	_
21-20	3449-3455	regard	abstract[167]|abstract[168]	new[167]|new[168]	_	_
21-21	3456-3458	to	abstract[167]|abstract[168]	new[167]|new[168]	_	_
21-22	3459-3468	oxidative	abstract[167]|abstract[168]|abstract|abstract[170]	new[167]|new[168]|giv|giv[170]	_	_
21-23	3469-3475	stress	abstract[167]|abstract[168]|abstract[170]	new[167]|new[168]|giv[170]	_	_
21-24	3476-3479	and	abstract[167]|abstract[168]	new[167]|new[168]	_	_
21-25	3480-3492	inflammatory	abstract[167]|abstract[168]|event[171]	new[167]|new[168]|new[171]	_	_
21-26	3493-3502	responses	abstract[167]|abstract[168]|event[171]	new[167]|new[168]|new[171]	_	_
21-27	3503-3504	.	_	_	_	_

#Text=Ageing is associated with decreased zinc status and hence increased Cu/Zn ratio , which is also observed in individuals with dementia .
22-1	3505-3511	Ageing	_	_	_	_
22-2	3512-3514	is	_	_	_	_
22-3	3515-3525	associated	_	_	_	_
22-4	3526-3530	with	_	_	_	_
22-5	3531-3540	decreased	abstract[173]	giv[173]	_	_
22-6	3541-3545	zinc	substance|abstract[173]	giv|giv[173]	coref	23-15
22-7	3546-3552	status	abstract[173]	giv[173]	_	_
22-8	3553-3556	and	_	_	_	_
22-9	3557-3562	hence	abstract[175]	giv[175]	coref	23-21[186_175]
22-10	3563-3572	increased	abstract[175]	giv[175]	_	_
22-11	3573-3578	Cu/Zn	abstract|abstract[175]	giv|giv[175]	coref	23-22
22-12	3579-3584	ratio	abstract[175]	giv[175]	_	_
22-13	3585-3586	,	_	_	_	_
22-14	3587-3592	which	_	_	_	_
22-15	3593-3595	is	_	_	_	_
22-16	3596-3600	also	_	_	_	_
22-17	3601-3609	observed	_	_	_	_
22-18	3610-3612	in	_	_	_	_
22-19	3613-3624	individuals	person[176]	giv[176]	_	_
22-20	3625-3629	with	person[176]	giv[176]	_	_
22-21	3630-3638	dementia	person[176]|abstract	giv[176]|giv	_	_
22-22	3639-3640	.	_	_	_	_

#Text=Therefore , this study aimed to investigate the relationship between plasma copper and serum zinc concentrations , as well as the Cu/Zn ratio , neurotrophic factors , cognitive function , and psychological distress in a sample of Australian community-dwelling older adults .
23-1	3641-3650	Therefore	_	_	_	_
23-2	3651-3652	,	_	_	_	_
23-3	3653-3657	this	abstract[178]	new[178]	_	_
23-4	3658-3663	study	abstract[178]	new[178]	_	_
23-5	3664-3669	aimed	_	_	_	_
23-6	3670-3672	to	_	_	_	_
23-7	3673-3684	investigate	_	_	_	_
23-8	3685-3688	the	abstract[179]	new[179]	_	_
23-9	3689-3701	relationship	abstract[179]	new[179]	_	_
23-10	3702-3709	between	abstract[179]	new[179]	_	_
23-11	3710-3716	plasma	abstract[179]|object|substance[181]	new[179]|new|giv[181]	_	_
23-12	3717-3723	copper	abstract[179]|substance[181]	new[179]|giv[181]	_	_
23-13	3724-3727	and	abstract[179]	new[179]	_	_
23-14	3728-3733	serum	abstract[179]|substance|abstract[184]	new[179]|new|giv[184]	_	_
23-15	3734-3738	zinc	abstract[179]|substance|abstract[184]	new[179]|giv|giv[184]	_	_
23-16	3739-3753	concentrations	abstract[179]|abstract[184]	new[179]|giv[184]	_	_
23-17	3754-3755	,	abstract[179]	new[179]	_	_
23-18	3756-3758	as	abstract[179]	new[179]	_	_
23-19	3759-3763	well	abstract[179]	new[179]	_	_
23-20	3764-3766	as	abstract[179]	new[179]	_	_
23-21	3767-3770	the	abstract[179]|abstract[186]	new[179]|giv[186]	_	_
23-22	3771-3776	Cu/Zn	abstract[179]|abstract|abstract[186]	new[179]|giv|giv[186]	_	_
23-23	3777-3782	ratio	abstract[179]|abstract[186]	new[179]|giv[186]	_	_
23-24	3783-3784	,	abstract[179]	new[179]	_	_
23-25	3785-3797	neurotrophic	abstract[179]|abstract[187]	new[179]|giv[187]	_	_
23-26	3798-3805	factors	abstract[179]|abstract[187]	new[179]|giv[187]	_	_
23-27	3806-3807	,	abstract[179]	new[179]	_	_
23-28	3808-3817	cognitive	abstract[179]|abstract[188]	new[179]|giv[188]	_	_
23-29	3818-3826	function	abstract[179]|abstract[188]	new[179]|giv[188]	_	_
23-30	3827-3828	,	abstract[179]	new[179]	_	_
23-31	3829-3832	and	abstract[179]	new[179]	_	_
23-32	3833-3846	psychological	abstract[179]|abstract[189]	new[179]|new[189]	_	_
23-33	3847-3855	distress	abstract[179]|abstract[189]	new[179]|new[189]	_	_
23-34	3856-3858	in	abstract[179]|abstract[189]	new[179]|new[189]	_	_
23-35	3859-3860	a	abstract[179]|abstract[189]|person[190]	new[179]|new[189]|new[190]	_	_
23-36	3861-3867	sample	abstract[179]|abstract[189]|person[190]	new[179]|new[189]|new[190]	_	_
23-37	3868-3870	of	abstract[179]|abstract[189]|person[190]	new[179]|new[189]|new[190]	_	_
23-38	3871-3881	Australian	abstract[179]|abstract[189]|person[190]|person[192]	new[179]|new[189]|new[190]|giv[192]	_	_
23-39	3882-3900	community-dwelling	abstract[179]|abstract[189]|person[190]|place|person[192]	new[179]|new[189]|new[190]|new|giv[192]	_	_
23-40	3901-3906	older	abstract[179]|abstract[189]|person[190]|person[192]	new[179]|new[189]|new[190]|giv[192]	_	_
23-41	3907-3913	adults	abstract[179]|abstract[189]|person[190]|person[192]	new[179]|new[189]|new[190]|giv[192]	_	_
23-42	3914-3915	.	_	_	_	_
